Imunon
IMNN
37 hedge funds and large institutions have $11.5M invested in Imunon in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 11 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 6
7% more call options, than puts
Call options by funds: $344K | Put options by funds: $322K
0.03% less ownership
Funds ownership: 0.08% → 0.05% (-0.03%)
8% less funds holding
Funds holding: 40 → 37 (-3)
27% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 11
30% less capital invested
Capital invested by funds: $16.4M → $11.5M (-$4.89M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$672K |
| 2 |
Renaissance Technologies
New York
|
+$410K |
| 3 |
State Street
Boston,
Massachusetts
|
+$259K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$226K |
| 5 |
Millennium Management
New York
|
+$217K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
-$4.83M |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$466K |
| 3 |
Morgan Stanley
New York
|
-$399K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$179K |
| 5 |
Squarepoint
New York
|
-$143K |
IMNN Hedge Fund Activity: Q2 2021 in Review
37 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q2 2021, worth a combined $11.5M — down 30% from $16.4M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of IMNN and 8 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 12 added.
The largest buyer was Vanguard Group, adding an estimated $672K. The largest seller was Altium Capital Management, exiting entirely with an estimated $4.83M sold.
- 37 institutional investors held Imunon (IMNN) as of Q2 2021, down from 40 in Q1 2021.
- Funds reported $11.5M of Imunon stock for Q2 2021, down 30% quarter-over-quarter.
- 8 funds opened new Imunon positions in Q2 2021 and 11 closed out, a net change of -3 holders.
- The largest Imunon buyer in Q2 2021 was Vanguard Group, an estimated $672K added.
- The largest Imunon seller in Q2 2021 was Altium Capital Management, an estimated $4.83M sold.
Based on aggregated 13F filings for Q2 2021.